Allianz Launches Two ETFs in Hotly Contested Market Niche
(Bloomberg) -- Allianz Investment Management is stepping into a growing corner of the $4 trillion ETF market with two funds that protect against stock losses.
The AllianzIM U.S. Large Cap Buffer10 Apr ETF, or AZAA, and the AllianzIM U.S. Large Cap Buffer20 Apr ETF, or AZBA, begin trading Monday. The exchange-traded funds will seek to track S&P 500 Price Return Index up to a stated cap on gains, while shielding investors against the first 10% and then 20% of losses should the gauge drop. So-called buffer funds -- a space dominated by niche issuer Innovator ETFs -- have attracted over $2 billion worth of inflows so far in 2020.
While parent Allianz SE -- which owns Pacific Investment Management Co. -- is no stranger to the ETF universe, it's the first venture into the space for its insurance-focused subsidiary. The company offers similarly structured variable annuities, which also have a set of defined outcomes. However, the ETF will reach a broader swath of risk-conscious individual investors than just through the annuity products alone, according to Allianz's Corey Walther.
“Investor appetite for risk seems to be decreasing across generations as baby boomers prepare for retirement and millennials report heightened sensitivity to loss,” said Walther, president of Allianz Life Financial Services.
Both Allianz ETFs will have expense ratios of 74 basis points.
Buffer ETFs have picked up popularity in 2020 as the coronavirus sent stocks plunging into the fastest bear market ever, before they rocketed out at a record clip. The defined-outcome ETF landscape was pioneered by Innovator, whose 46 buffer funds have attracted roughly $2.9 billion in assets since the first were launched in 2018. Innovator has filed patent applications for the processes and methodologies behind the products and trademark applications for the names “Buffer ETF” and “Defined Outcome.”
But competition is building. In addition to Allianz, issuer First Trust has its own buffer ETFs. New York Life Investments's IndexIQ unit has also filed plans for defined-outcome ETFs, after debuting several such unit investment trusts.
“We are not surprised to see some of the largest providers of annuities noticing advisors' preference for buffer strategies in the ETF vehicle rather than the annuity wrapper and deciding to copy the processes behind our patent-pending Defined Outcome ETFs,” said Bruce Bond, chief executive officer of Innovator. “This further validates Innovator's Defined Outcome ETFs and illustrates the significant threat that they pose to the multi-trillion dollar insurance industry.”
The uptick in issuance should help boost awareness of buffer ETFs and ultimately benefit Innovator, according to Old Mission Holdings.
“Innovator came out with the first and really turned some heads,” said Harry Whitton, head of ETF sales and trading at the market-maker firm. “When you get these big marketing groups behind them, like Innovator is building, you'll see more and more people talking about them.”
For Allianz's Walther, Monday's launch is the first of several from the insurance company.
“We started with an ETF that was simplistic, easy to understand, familiar with clients,” Walther said. “Our intent is to continue monitor that and test new areas that might be opportunities or additional gaps where we could continue to expand.”
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.